Free shipping on all orders over $ 500

MS0124 

Cat. No. M27917
MS0124  Structure
Size Price Availability Quantity
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

MS0124 is a potent selective G9a-like protein (GLP) inhibitor with IC50 values of 13±4 nM and 440±63 nM for GLP and G9a,respectively.

Chemical Information
Molecular Weight 387.48
Formula C20H29N5O3
CAS Number 1197196-63-6
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Yan Xiong, et al. Bioorg Med Chem. Structure-activity relationship studies of G9a-like protein (GLP) inhibitors

[2] Yan Xiong, et al. J Med Chem. Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase

Related Histone Methyltransferase Products
SAH-EZH2

SAH-EZH2, a stable EZH2 α-helical peptide, is an EZH2/EED interaction inhibitor.

UNC4976

UNC4976 is a positive allosteric modulator (PAM) peptidomimetic of CBX7 chromodomain binding to nucleic acids.

C21

C21 is a potent, irreversible, and selective PRMT1 inhibitor with an IC50 of 1.8 μM.

EZH2-IN-15

EZH2-IN-15 (SHR2554) is a EZH2 inhibitor.

NSD-IN-2

NSD-IN-2 is a potent and irreversible NSD1 inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: MS0124  supplier, Histone Methyltransferase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.